GeneDx Holdings annual operating margin
2019
2020
2021
2022
2023
2024
2025
GeneDx Holdings Operating Margin Growth & History (WGS)
GeneDx Holdings's operating margin was −3.06% for fiscal 2025.
View full GeneDx Holdings company overviewGeneDx Holdings annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −3.06% | +4.54 pp |
| 2024 | 2024-12-31 | −7.60% | +81.55 pp |
| 2023 | 2023-12-31 | −89.15% | +195.32 pp |
| 2022 | 2022-12-31 | −284.48% | −74.22 pp |
| 2021 | 2021-12-31 | −210.25% | −75.30 pp |
| 2020 | 2020-12-31 | −134.95% | −119.45 pp |
| 2019 | 2019-12-31 | −15.50% | — |
GeneDx Holdings quarterly operating margin
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −15.25% | −23.98 pp |
| Q1 2026 | 2026-03-31 | −56.20% | −50.98 pp |
| Q4 2025 | 2025-12-31 | −11.77% | −20.97 pp |
| Q3 2025 | 2025-09-30 | −2.78% | +7.34 pp |
| Q2 2025 | 2025-06-30 | 8.73% | +23.73 pp |
| Q1 2025 | 2025-03-31 | −5.22% | +16.66 pp |
| Q4 2024 | 2024-12-31 | 9.21% | +53.87 pp |
| Q3 2024 | 2024-09-30 | −10.12% | +70.49 pp |
| Q2 2024 | 2024-06-30 | −15.00% | +90.98 pp |
| Q1 2024 | 2024-03-31 | −21.88% | +118.05 pp |
| Q4 2023 | 2023-12-31 | −44.66% | +484.89 pp |
| Q3 2023 | 2023-09-30 | −80.61% | +28.50 pp |
| Q2 2023 | 2023-06-30 | −105.99% | +343.70 pp |
| Q1 2023 | 2023-03-31 | −139.93% | +25.63 pp |
| Q4 2022 | 2022-12-31 | −529.56% | −329.25 pp |
| Q3 2022 | 2022-09-30 | −109.11% | +95.31 pp |
| Q2 2022 | 2022-06-30 | −449.69% | −353.02 pp |
| Q1 2022 | 2022-03-31 | −165.56% | +140.75 pp |
| Q4 2021 | 2021-12-31 | −200.31% | −200.15 pp |
| Q3 2021 | 2021-09-30 | −204.42% | — |
| Q2 2021 | 2021-06-30 | −96.67% | — |
| Q1 2021 | 2021-03-31 | −306.31% | — |
| Q3 2020 | 2020-09-30 | −0.15% | — |
GeneDx Holdings operating margin trends
Over the last five reported fiscal years, GeneDx Holdings's operating margin increased from −134.95% to −3.06%, a change of +131.89 percentage points. The latest reported quarter, Q2 2026, shows −15.25%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review GeneDx Holdings filings at SEC.gov ↗